Vaccines Market Size was valued at USD 67.51 Bn in 2022 and is expected to reach USD 151 Bn by 2030 and grow at a CAGR of 10.6% during the forecasted period 2023-2030.
The Vaccines Market Report provides a comprehensive analysis of the global Vaccines market, highlighting key trends, growth drivers, challenges, and opportunities. The report aims to assist industry stakeholders in making informed decisions and formulating effective strategies.
The vaccines market has witnessed significant growth in recent years, driven by the increasing prevalence of infectious diseases and the growing awareness about the importance of immunization. Vaccines play a crucial role in preventing the spread of diseases and protecting individuals from life-threatening infections.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2903
One of the key factors driving the growth of the vaccines market is the rising global population, which leads to a higher demand for vaccination programs. Additionally, advancements in technology have enabled the development of more effective and targeted vaccines, further boosting market growth.
Furthermore, governments across various countries are actively promoting vaccination campaigns to control outbreaks and reduce healthcare costs associated with treating vaccine-preventable diseases. This has led to increased funding for research and development activities in the vaccines sector.
Moreover, with the ongoing COVID-19 pandemic, there has been an unprecedented focus on vaccine development. The race to develop safe and effective COVID-19 vaccines has accelerated innovation in this field, leading to collaborations between pharmaceutical companies, research institutions, and governments worldwide.
KEY MARKET SEGMENTS
- Live Attenuated
By Route of Administration
By Disease indication
- Viral diseases
- Bacterial Diseases
By Age Group
Major Players Listed in the Report are as Follows:
Sanofi, Pfizer, GlaxoSmithKline plc, Merck & Co, Inc, Inovio pharmaceuticals, Inc, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Novartis AG, Moderna and others.
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)